How Does Marketing for Healthcare Work Today?

Marketing for healthcare no longer sits downstream of clinical operations. It is the regulated layer where patient choice, digital infrastructure, and HIPAA-governed communication actually meet. For treatment center CMOs, that means the function is judged less by impressions or session counts and more by whether a compliant outreach system produces qualified verification-of-benefits checks and admissions calls.

Three forces have rewired the discipline. First, the federal definition of “marketing” under the HIPAA Privacy Rule draws a hard line between communications that require written patient authorization and those that fall under treatment or care coordination ¹⁰. Second, the engagement infrastructure marketers used to promise — portals, secure messaging, telehealth access — is now operational reality across most U.S. hospitals, which raises the floor for what counts as a credible value proposition ¹. Third, patient trust in digital healthcare hinges on visible privacy protections and human interaction cues, not on copy that simply asserts convenience ⁵.

The practical consequence is that admissions-facing channels — paid search for medication-assisted treatment terms, alumni testimonials, retargeting, intake forms — each carry compliance, modality, and substantiation risk at the same time. A campaign can be on-message and still out of policy if PHI touches an ad platform without a business associate relationship ¹¹. A telehealth landing page can convert and still mislead if it ignores how behavioral health patients experience modality choice ¹³.

The sections that follow treat healthcare marketing as four operating constraints CMOs work inside: what HIPAA legally classifies as marketing, what trust actually requires, how modality should be messaged, and how clinical claims get substantiated without tripping AMA standards.

The word “marketing” carries a specific federal meaning that does not match how most CMOs use it internally. Under HHS guidance interpreting the HIPAA Privacy Rule, a communication is “marketing” when it encourages a recipient to purchase or use a product or service, and with limited exceptions, written patient authorization is required before protected health information (PHI) can be used or disclosed for that purpose ¹⁰. The same guidance carves out communications about a covered entity’s own services, treatment, case management, and care coordination — categories that absorb a meaningful share of what admissions teams already do ¹⁰.

That distinction is the operating spine of compliant outreach. A relapse-prevention email sent to a former patient describing the center’s continuing care program can fall inside care coordination. The same email, if it promotes a third party’s product in exchange for remuneration, becomes marketing and requires authorization ^{10, 11}. The legal category is determined by intent, content, and money flow — not by which department in the org chart sent it.

The marketing pitch for digital convenience used to outrun what most providers could actually deliver. That gap has closed. Between 2021 and 2024, U.S. hospital adoption of Health IT-enabled patient engagement capabilities — portals, secure messaging, telehealth access, and related tools — rose from 56% to 69% in inpatient settings and from 49% to 64% in outpatient settings ¹. Engagement infrastructure is no longer a differentiator on its own. It is the baseline, and a treatment center claiming “easy digital access” is now making a category-table-stakes claim, not a competitive one.

The strategic implication is sharper than it first appears. When portals and telehealth scheduling were scarce, the marketing job was to advertise their existence. When most peers have shipped them, the job becomes to differentiate on what happens inside them: response time on secure messages, the clinical depth of an intake screen, whether a verification-of-benefits flow takes ninety seconds or thirty minutes, whether an alumni messaging channel actually reaches a human within the same business day. Channel parity has moved the competitive line from feature presence to feature performance.

That shift changes what admissions-facing content should emphasize. Pages that lead with “we offer telehealth” or “book online” describe a 2021 advantage. Pages that show what the first 24 hours after a call look like — who answers, how insurance is verified, when the clinical assessment happens, how a virtual session is set up if that is the chosen modality — describe operations the engagement infrastructure now supports. The ONC data also flags a caveat worth respecting: adoption is not uniform, with lower-resourced and rural hospitals lagging the national curve ¹. Behavioral health marketers running national paid campaigns should not assume every referral source or partner facility offers the same digital experience their owned properties do.

There is a second-order effect for measurement. As engagement tools become ubiquitous, the meaningful signal moves from acquisition metrics — portal sign-ups, app installs, telehealth landing-page conversions — toward sustained use and downstream clinical contact. Preliminary digital health engagement research underscores how variable real-world adherence remains even among enrolled users, with substantial drop-off between onboarding and completion of intended program milestones ⁶. That is a small-cohort observation, not an industry benchmark, but it points marketers toward a more honest model: an admissions call that arrives because a portal nudge worked is worth more than a portal sign-up that never reaches a clinician. The infrastructure caught up. Now the work is to use it to produce contact with people, not credit for digital touches.

Trust in behavioral health marketing is not a brand attribute. It is a measurable composite of signals patients read on a page, in a search result, and during the first thirty seconds of an admissions call. A 2025 systematic review of 49 studies on trust in digital healthcare found that perceived risk and privacy concerns were negatively associated with trust, while visible human interaction, demonstrated data accuracy, and support for users with varying digital literacy were positively associated with it ⁵. For a CMO running paid search on medication-assisted treatment terms or scheduling pages for intensive outpatient programs, those drivers translate into specific page elements, not abstract brand language.

The funnel context sharpens what each driver costs to ignore. A prospect searching for a treatment center is rarely a casual browser. Many are family members in crisis, individuals weighing whether to disclose a substance use disorder, or referred patients comparing two or three options. Online physician selection research shows that information quality and reputation cues materially affect provider choice in digital channels, with implications that extend to behavioral health where stigma raises the bar for what counts as credible ¹². A page that buries credentials, omits the modality of the first visit, or routes the call to an anonymous queue does not just convert poorly. It fails the trust filter before conversion is even on the table.

Telehealth marketing has aged out of the convenience pitch. The Health Affairs study on visit modality in behavioral health found that a substantial share of patients felt they had limited or no say in whether their visits were virtual or in person, even when they held strong preferences ¹³. The constraint was not the technology. It was scheduling practice, provider availability, and organizational defaults that quietly removed the choice patients believed they had.

For a treatment center CMO, that finding rewrites the brief. Promoting telehealth as freedom while operations route patients into whichever modality has open capacity creates a gap between the ad and the experience. The gap shows up in admissions calls that go cold after the first scheduling conversation, in alumni feedback, and in reputation channels that the marketing team eventually has to manage. Modality copy that survives contact with the patient is copy that describes the actual choice architecture: which modalities are offered for which programs, when virtual is clinically appropriate, when in-person is required, and who decides.

The satisfaction picture reinforces the point. Direct-to-consumer telehealth satisfaction landed at 730 on a 1,000-point scale, slightly down year over year ¹⁴. That decline is small, but the direction matters. Patients who tried virtual care during the pandemic surge are now comparing it to in-person experiences with more discrimination. Marketing that treats telehealth as an unqualified upgrade is writing for the 2021 prospect, not the 2024 one.

The operational discipline is to match modality claims to clinical realities. Telepsychology guidance consolidates around domains that admissions content rarely addresses head-on: technical competence, informed consent specific to virtual care, confidentiality boundaries in the home environment, and clinical appropriateness for the presenting condition ⁷. A landing page that promises virtual intensive outpatient programming should name the conditions the program treats virtually, the conditions that require an in-person component, and what triggers a modality change mid-treatment. That level of specificity does two things at once. It complies with substantiation expectations, and it removes the patient surprise that drives the satisfaction decline.

For admissions content, three edits move modality messaging from promotional to credible:

1. Replace “telehealth available” with the specific programs offered virtually and the eligibility criteria.
2. Name the clinical reasons in-person care may be recommended, so the patient encountering that recommendation later does not feel bait-and-switched.
3. Give the prospect an explicit way to state a modality preference during the admissions call, and train the team to honor it where clinically possible.

Treatment centers that document modality choice as part of intake convert the Health Affairs finding from a liability into a differentiator ¹³.

Behavioral health marketing lives or dies on what it says about treatment. Outcomes language, medication references, and program descriptions sit at the intersection of professional advertising standards, the AMA’s direct-to-consumer advertising policy, and the broader marketing ethics most CMOs already work under. The standards do not prohibit clinical content. They constrain how it is framed.

The AMA’s policy on direct-to-consumer advertising is explicit on one point that travels well into behavioral health: ads should not encourage self-diagnosis or self-treatment, and should refer patients to physicians for more information ⁸. The BMJ summary of the same guidelines adds the substantiation half — advertisements must offer balanced discussion of benefits and risks, identify the population at risk, and avoid comparative claims that imply superiority without evidence ⁹. Applied to a medication-assisted treatment landing page, that rules out copy that positions buprenorphine or naltrexone as a solution the reader should select on their own. It permits, and arguably requires, copy that describes who the medication is clinically appropriate for, what the assessment process looks like, and that a prescriber makes the call.

Three operational disciplines keep clinical claims defensible:

• Outcomes language stays specific and scoped. “Patients in our 90-day program show measurable reduction in cravings” is a defensible claim only if the program has internal data, the measure is defined, and the qualifier is honest. “Industry-leading recovery rates” is the kind of comparative claim the AMA framework warns against ⁹.
• Medication content stays educational, not promotional — naming the medications offered, the conditions they treat, and the clinical evaluation that determines candidacy, with the prescribing decision routed to a clinician ⁸.
• Risk and benefit appear in the same field of view. A page describing a therapy approach should disclose what it does not treat, what side effects or limitations apply, and when an alternative is indicated ⁹.

The cross-sector ethical layer sits on top of HIPAA and the AMA’s clinical standards. The American Marketing Association’s Statement of Ethics names the operating principles most directly: do no harm, maintain integrity, and embrace transparency, honesty, and responsibility in commercial communication ¹⁵. In a behavioral health funnel where prospects are often in crisis, those principles translate into concrete edits — no urgency tactics that exploit ambivalence, no testimonial selection that excludes negative outcomes, no pricing claims that obscure what a verification of benefits will actually surface. Admissions content that meets the AMA substantiation bar and the AMA Statement of Ethics standard tends to convert the prospects most likely to complete treatment, because the page already filters for fit before the call.

The four constraints discussed so far — HIPAA’s legal definition of marketing, the trust mechanics behind digital provider selection, modality choice in behavioral health, and substantiation standards on clinical claims — each land somewhere specific in the admissions funnel. Treating them as separate compliance topics misses the point. They are interlocking inputs to the same pipeline a CMO is accountable for.

The pattern across the four rows is that each constraint is felt downstream of where it is set. A pixel decision made by a media buyer surfaces in a breach review six months later. A landing-page headline written without trust inputs surfaces as a depressed call rate the analytics team attributes to channel fatigue. A modality claim that operations cannot honor surfaces as alumni complaints and a softer reputation score the next quarter. Healthcare marketing functions that treat these as one operating system — rather than four separate review queues — are the ones producing admissions calls at a defensible cost. That integrated posture is the category Active Marketing operates in for behavioral health and addiction treatment organizations.